Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia

Single risk factors, such as hypertension and dyslipidemia, can combine to exacerbate the development and severity of cardiovascular disease. Treatment goals may be more effectively achieved if multiple disease factors are targeted with combination treatment. We enrolled 202 patients who were random...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Clin Hypertens (Greenwich)
Κύριοι συγγραφείς: Jin, Xuan, Kim, Moo Hyun, Han, Ki Hoon, Hong, Soon Jun, Ahn, Jeong‐Cheon, Sung, Jung‐Hoon, Cho, Jin‐Man, Lee, Han Cheol, Choi, So‐Yeon, Lee, Kyounghoon, Kim, Woo‐Shik, Rhee, Moo‐Yong, Kim, Ju Han, Hong, Seung Pyo, Yoo, Byung Su, Cho, Eun Joo, Lee, Jae‐Hwan, Kim, Pum‐Joon, Park, Chang‐Gyu, Hyon, Min Su, Shin, Jin Ho, Lee, Sang Hyun, Sung, Ki Chul, Hwang, Jinyong, Kwon, Kihwan, Chae, In‐Ho, Seo, Jeong‐Sook, Kim, Hyungseop, Lee, Hana, Cho, Yoonhwa, Kim, Hyo‐Soo
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley and Sons Inc. 2020
Θέματα:
Combination Therapy
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7692919/
https://ncbi.nlm.nih.gov/pubmed/32937023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13893
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια